CIK 0001590877 · Non-accelerated filer<br>Smaller reporting company
REGENXBIO Inc.
Sign in to watch- Ticker
- RGNX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 471851754
- Phone
- 240-552-8181
- Business address
- 9804 MEDICAL CENTER DRIVE, ROCKVILLE, MD, 20850
- Former names
- ReGenX Biosciences, LLC
- Open-market buys, last 90 days
- $949,381
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$949,381. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-05-29 | Tasse Daniel Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2020-05-29 | STUMP DAVID C Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2020-05-29 | KARABELAS ARGERIS N Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2020-05-29 | HAYDEN DONALD J JR Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2020-05-29 | Glucksmann Alexandra Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2020-05-29 | Fox Allan M. Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2020-05-29 | BESHAR LUKE M Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2020-05-29 | Abdun-Nabi Daniel Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2020-05-11 | Vasista Vittal Chief Financial Officer | Option exercise | +500 | $13.09 | $7K | 207,215 |
| 2020-05-11 | Vasista Vittal Chief Financial Officer | Sale | −500 | $40.00 | $20K | 206,715 |
| 2020-05-11 | Vasista Vittal Chief Financial Officer | Option exercise · Employee Stock Option (Right to Buy) | −500 | 17,374 | ||
| 2020-05-08 | Vasista Vittal Chief Financial Officer | Option exercise | +2,500 | $13.09 | $33K | 213,715 |
| 2020-05-08 | Vasista Vittal Chief Financial Officer | Sale | −7,000 | $40.18 | $281K | 206,715 |
| 2020-05-08 | Vasista Vittal Chief Financial Officer | Option exercise · Employee Stock Option (Right to Buy) | −2,500 | 17,874 | ||
| 2020-04-24 | Vasista Vittal Chief Financial Officer | Option exercise | +3,000 | $13.09 | $39K | 223,215 |
| 2020-04-24 | Vasista Vittal Chief Financial Officer | Sale | −12,000 | $40.11 | $481K | 211,215 |
| 2020-04-24 | Vasista Vittal Chief Financial Officer | Option exercise · Employee Stock Option (Right to Buy) | −3,000 | 20,374 | ||
| 2020-04-23 | Vasista Vittal Chief Financial Officer | Option exercise | +3,000 | $13.09 | $39K | 223,215 |
| 2020-04-23 | Vasista Vittal Chief Financial Officer | Sale | −3,000 | $40.00 | $120K | 220,215 |
| 2020-04-23 | Vasista Vittal Chief Financial Officer | Option exercise · Employee Stock Option (Right to Buy) | −3,000 | 23,374 |
Page 22 of 25 · 494 trades